Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Short Interest Update

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) saw a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 12,200 shares, anincreaseof50.6% from the July 15th total of 8,100 shares. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days. Based on an average trading volume of 0 shares, the short-interest ratio is currently ∞ days.

Laboratorios Farmaceuticos Rovi Stock Performance

LABFF stock opened at C$65.86 on Thursday. The firm has a 50 day moving average price of C$65.86 and a 200-day moving average price of C$65.86. Laboratorios Farmaceuticos Rovi has a 52-week low of C$65.86 and a 52-week high of C$65.86.

Laboratorios Farmaceuticos Rovi Company Profile

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.